DE3853577D1 - Benzyliden-Malononitril-Derivate zur Hemmung von proliferativen Prozessen in Säugetierzellen. - Google Patents

Benzyliden-Malononitril-Derivate zur Hemmung von proliferativen Prozessen in Säugetierzellen.

Info

Publication number
DE3853577D1
DE3853577D1 DE3853577T DE3853577T DE3853577D1 DE 3853577 D1 DE3853577 D1 DE 3853577D1 DE 3853577 T DE3853577 T DE 3853577T DE 3853577 T DE3853577 T DE 3853577T DE 3853577 D1 DE3853577 D1 DE 3853577D1
Authority
DE
Germany
Prior art keywords
mammalian cells
benzylidene
proliferative processes
chem
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3853577T
Other languages
English (en)
Other versions
DE3853577T2 (de
Inventor
Alexander Levitzki
Chaim Gilon
Michael Chorev
Aviv Gazit
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yissum Research Development Co of Hebrew University of Jerusalem
Original Assignee
Yissum Research Development Co of Hebrew University of Jerusalem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL84937A external-priority patent/IL84937A/xx
Priority claimed from IL88354A external-priority patent/IL88354A0/xx
Application filed by Yissum Research Development Co of Hebrew University of Jerusalem filed Critical Yissum Research Development Co of Hebrew University of Jerusalem
Application granted granted Critical
Publication of DE3853577D1 publication Critical patent/DE3853577D1/de
Publication of DE3853577T2 publication Critical patent/DE3853577T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
DE3853577T 1987-12-24 1988-12-21 Benzyliden-Malononitril-Derivate zur Hemmung von proliferativen Prozessen in Säugetierzellen. Expired - Fee Related DE3853577T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL84937A IL84937A (en) 1987-12-24 1987-12-24 Pharmaceutical compositions comprising benzylidene- malononitrile derivatives for the inhibition of proliferative processes in mammalian cells, certain such novel compounds and their preparation
IL88354A IL88354A0 (en) 1988-11-10 1988-11-10 Pharmaceutical compositions comprising benzylidene-malononitrile derivatives for the inhibition of proliferative processes in mammalian cells,certain such novel compounds and their preparation

Publications (2)

Publication Number Publication Date
DE3853577D1 true DE3853577D1 (de) 1995-05-18
DE3853577T2 DE3853577T2 (de) 1995-08-31

Family

ID=26321754

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3853577T Expired - Fee Related DE3853577T2 (de) 1987-12-24 1988-12-21 Benzyliden-Malononitril-Derivate zur Hemmung von proliferativen Prozessen in Säugetierzellen.

Country Status (8)

Country Link
EP (2) EP0322738B1 (de)
JP (2) JP2806954B2 (de)
AT (1) ATE120955T1 (de)
AU (1) AU632992B2 (de)
CA (1) CA1334826C (de)
DE (1) DE3853577T2 (de)
ES (1) ES2073398T3 (de)
NZ (1) NZ227436A (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68917357T2 (de) * 1988-04-28 1995-01-26 Suntory Ltd Derivate der Coffeinsäure und pharmazeutische Zusammensetzungen, die sie enthalten.
EP0527181A4 (en) * 1990-04-16 1993-04-07 Rorer International (Holdings) Heterocyclicethenediyl compounds which inhibit egf receptor tyrosine kinase
NZ243082A (en) 1991-06-28 1995-02-24 Ici Plc 4-anilino-quinazoline derivatives; pharmaceutical compositions, preparatory processes, and use thereof
CA2080554A1 (en) * 1991-10-15 1993-04-16 Mitsubishi Chemical Corporation Styrene derivatives
JPH05301838A (ja) * 1991-10-15 1993-11-16 Mitsubishi Kasei Corp スチレン誘導体
DE4230262A1 (de) * 1992-09-10 1994-03-17 Behringwerke Ag Substituierte Phenole, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von zellproliferationsbedingten Erkrankungen
US5763441A (en) * 1992-11-13 1998-06-09 Sugen, Inc. Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
US5981569A (en) * 1992-11-13 1999-11-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Substituted phenylacrylonitrile compounds and compositions thereof for the treatment of disease
GB9323290D0 (en) 1992-12-10 1994-01-05 Zeneca Ltd Quinazoline derivatives
IL107736A (en) * 1993-11-24 2001-01-11 Yissum Res Dev Co Pharmaceutical composition for the prevention of septic shock and for the treatment of chronic inflammatory diseases
IL119069A0 (en) 1996-08-14 1996-11-14 Mor Research Applic Ltd Pharmaceutical composition comprising tyrphostins
GB9802522D0 (en) 1998-02-06 1998-04-01 Montford University De Hydroxylation activated prodrugs
DE69918950T2 (de) 1998-02-06 2005-07-28 De Montfort University Durch hydroxylierung aktivierte medikamentvorstufen
GB2334256A (en) 1998-02-12 1999-08-18 Univ Montfort Hydroxylation activated prodrugs
US6432979B1 (en) 1999-08-12 2002-08-13 American Cyanamid Company Method of treating or inhibiting colonic polyps and colorectal cancer
GB2378948B (en) * 2000-04-13 2004-11-10 Hsc Res Dev Lp Novel compounds for modulating cell proliferation
US6582919B2 (en) 2001-06-11 2003-06-24 Response Genetics, Inc. Method of determining epidermal growth factor receptor and HER2-neu gene expression and correlation of levels thereof with survival rates
EP1435894A4 (de) * 2001-07-23 2005-07-06 Galileo Pharmaceuticals Inc Zytoprotektive verbindungen, pharmazeutische und kosmetische formulierungen und verfahren
EP1453500A1 (de) * 2001-10-11 2004-09-08 The Hospital For Sick Children Styrol-acrylnitril derivate und ihre verwendung zur förderung von myelopoiesis
JP2007530455A (ja) 2004-03-26 2007-11-01 エイチエスシー リサーチ アンド ディベロップメント リミテッド パートナーシップ 細胞増殖を調節する化合物
MX2010004625A (es) 2007-10-29 2010-05-20 Natco Pharma Ltd Nuevos derivados de 4(tetrazol-5-il)-quinazolina como agentes anticancerosos.
CA2954004C (en) 2014-07-03 2023-10-10 NAN Global, LLC Methods and compositions for treating obesity, preventing weight gain, promoting weight loss, promoting slimming, or treating or preventing the development of diabetes
CA3112350A1 (en) * 2018-10-04 2020-04-09 Hydro-Quebec Additives for electrolytes in li-ion batteries
IL310994A (en) 2021-08-25 2024-04-01 GARC?A SADA Fernando Preparations and methods for preventing or reducing the risk of metabolic syndrome

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3522188A (en) * 1962-06-27 1970-07-28 Gaf Corp Use of alpha-alkyl (or alkenyl) benzylidene malononitriles as u.v. absorbers,and stabilized compositions and light filters containing same
US4064266A (en) * 1975-09-29 1977-12-20 Ici Australia Limited Compositions for killing internal parasites containing 3-tert-alkyl-4-hydroxy-5-halo-benzylidene-malonitriles
AU500541B2 (en) * 1975-09-29 1979-05-24 Ici Australia Limited Substituted benzylidene malonitriles
JPS6239523A (ja) * 1985-08-14 1987-02-20 Kanegafuchi Chem Ind Co Ltd 酵素阻害剤
US4781750A (en) * 1985-08-27 1988-11-01 Rohm And Haas Company Herbicidally active enols
YU213587A (en) * 1986-11-28 1989-06-30 Orion Yhtymae Oy Process for obtaining new pharmacologic active cateholic derivatives
DE68917357T2 (de) * 1988-04-28 1995-01-26 Suntory Ltd Derivate der Coffeinsäure und pharmazeutische Zusammensetzungen, die sie enthalten.

Also Published As

Publication number Publication date
CA1334826C (en) 1995-03-21
ES2073398T3 (es) 1995-08-16
JPH02138238A (ja) 1990-05-28
AU632992B2 (en) 1993-01-21
ATE120955T1 (de) 1995-04-15
DE3853577T2 (de) 1995-08-31
EP0614661A2 (de) 1994-09-14
EP0322738B1 (de) 1995-04-12
AU2736088A (en) 1989-06-29
JP2806954B2 (ja) 1998-09-30
EP0322738A2 (de) 1989-07-05
EP0614661A3 (de) 1994-11-02
EP0322738A3 (de) 1991-05-08
NZ227436A (en) 1992-10-28
JPH10279477A (ja) 1998-10-20

Similar Documents

Publication Publication Date Title
DE3853577D1 (de) Benzyliden-Malononitril-Derivate zur Hemmung von proliferativen Prozessen in Säugetierzellen.
HUP0100615A2 (hu) Szubsztituált 2-(2,6-dioxo-3-fluoro-piperidin-3-il)-izoindolinok és ezek alkalmazása TNFalfa-szint csökkentésére
MX9306831A (es) Nuevos compuestos heterociclicos.
SE8201854L (sv) N-substituerade amino-aminosyror
ES2197160T3 (es) Antagonistas fibronogeno bicicliclos.
HUP0102793A2 (hu) Agydaganat kezelésére szolgáló kinazolinok és ezeket tartalmazó gyógyszerkészítmények
ES8404990A1 (es) Un procedimiento para la preparacion de derivados de prolina.
ES8401941A1 (es) Procedimiento para la preparacion de derivados de acido espiro (4.(3+n))-2-aza-3carboxilico.
EP0353955A3 (de) Chemische Verbindungen
EA200000614A1 (ru) 2,3-замещенные соединения индола в качестве ингибиторов сох-2
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
TW368501B (en) 7-(2-aminoethyl)-benzothiazolones
ES2010284A6 (es) Procedimiento para preparar derivados de tiourea.
KR960022476A (ko) 디페닐 디설파이드 화합물
ES2016017A6 (es) Procedimiento para preparar derivados de acido 1,1-dioxocefem-4-carbotiolico.
DK0514942T3 (da) Hidtil ukendte benzopyranderivater og fremgangsmåder til fremstilling deraf
MX9206930A (es) Nuevos compuestos
ATE224872T1 (de) Azetidinonderivate zur behandlung von hcmv entzündungen
EA200000374A2 (ru) Новые соединения 2,3-метаноаминокислоты, способ их получения и содержащие их фармацевтические композиции
FI872997A0 (fi) Amidderivat.
ATE94050T1 (de) Mittel zur verhinderung von zahnbelagbildung.
IL116382A0 (en) Trisubstituted t hoxanthines and pharmaceutical compositions containing the same
ES8302719A1 (es) Un procedimiento para preparar compuestos de cefem
DK602383D0 (da) 1,1-diphenylpropanolderivater
DE2963724D1 (en) Clavulanic acid derivatives, their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee